Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation.
about
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNSGlycogen synthase kinase 3: more than a namesakeGlycogen synthase kinase 3: a point of convergence for the host inflammatory responseWnt/beta-catenin signaling and small molecule inhibitorsLeptin regulates tau phosphorylation and amyloid through AMPK in neuronal cellsSignaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated MacrophagesThe GSK-3 family as therapeutic target for myocardial diseasesThe many faces and functions of β-cateninp38 MAPK in cardioprotection - are we there yet?GSK3β and the control of infectious bacterial diseasesGSK-3 as potential target for therapeutic intervention in cancerSignal transducer and activator of transcription 3 (STAT3) protein suppresses adenoma-to-carcinoma transition in Apcmin/+ mice via regulation of Snail-1 (SNAI) protein stabilityProstate specific membrane antigen (PSMA): a novel modulator of p38 for proliferation, migration, and survival in prostate cancer cellsMitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.Andrographolide induces Nrf2 and heme oxygenase 1 in astrocytes by activating p38 MAPK and ERKMicrotubules Inhibit E-Cadherin Adhesive Activity by Maintaining Phosphorylated p120-Catenin in a Colon Carcinoma Cell Model.GSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in miceThe Cytoprotective Effect of Hyperoside against Oxidative Stress Is Mediated by the Nrf2-ARE Signaling Pathway through GSK-3β InactivationGSK-3: Functional Insights from Cell Biology and Animal Models.Is glycogen synthase kinase-3 a central modulator in mood regulation?Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways.GSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of SlugGSK3beta is involved in JNK2-mediated beta-catenin inhibition.Identification of crosstalk between phosphoprotein signaling pathways in RAW 264.7 macrophage cells.Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A.A noncatalytic domain of glycogen synthase kinase-3 (GSK-3) is essential for activityDistinct effects of p38alpha deletion in myeloid lineage and gut epithelia in mouse models of inflammatory bowel disease.Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivoAlterations in the cerebellar (Phospho)proteome of a cyclic guanosine monophosphate (cGMP)-dependent protein kinase knockout mouse.Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling.Evolutionarily conserved role of calcineurin in phosphodegron-dependent degradation of phosphodiesterase 4DGlycogen synthase kinase-3 and p38 MAPK are required for opioid-induced microglia apoptosisAnalysis of tumor suppressor genes based on gene ontology and the KEGG pathway.Prenatal alcohol exposure alters p35, CDK5 and GSK3β in the medial frontal cortex and hippocampus of adolescent micePlatelet-derived growth factor-BB restores HIV Tat -mediated impairment of neurogenesis: role of GSK-3β/β-catenin.Alternative splicing of the porcine glycogen synthase kinase 3β (GSK-3β) gene with differential expression patterns and regulatory functionsMultiple alternative splicing and differential expression pattern of the glycogen synthase kinase-3β (GSK3β) gene in goat (Capra hircus)Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation via β-catenin signaling.BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathwaysMitogen-activated protein kinases promote WNT/beta-catenin signaling via phosphorylation of LRP6.
P2860
Q21129334-5DC99097-3F0D-404E-BD29-8BA8DB895C17Q24315635-FA4CE69F-E581-41D7-9DD4-AF918AD1117CQ24597129-A740EF63-CD2A-43FC-B09F-B50BFEDF56F6Q24597197-7C7D2D44-A86E-42AA-B178-9459A46B1EB5Q24655644-2197F056-492B-4489-AFBB-BBC855EBEF62Q26783748-5193D410-68A3-4682-B4F5-75156271FB38Q26861134-93CD14DC-7C5A-4331-8942-74B303376EC1Q26865781-3FE2A07E-EB7E-42CE-A4A8-C7F910814007Q27001653-0FFA06A3-8871-4752-AE47-4112D983A6BAQ27013766-8D6CFDF2-33B9-4AB6-985D-739DB1AC4C4AQ27013811-D6116795-FB56-4F2D-B212-B8554EF4CD33Q28264306-ECDF30CD-77B7-44CC-B1C3-5C7D239B8850Q28281777-17D2BA14-56A6-4960-A9A6-3152767B6B14Q28296128-03C75D91-9770-4BFD-894B-730388E2473FQ28389948-AEE148A0-8FC1-448B-AE1E-F9E1703B4DA9Q28553120-AADE1EB4-1D36-4749-8EFB-DAD4302D4459Q28590516-BD539971-BECA-40BF-93CA-48A7490A68FEQ30361898-0E701A70-8F1A-455E-AAC9-BD23CF3480C8Q30472813-59C1811B-B76C-4FDE-BC39-37B61EA8C4EBQ30475816-87EED8BD-30FA-4C65-8BF6-0E1488376719Q30485381-F549B225-7B88-44FD-B66A-79D1754EBC7EQ30583575-B39D1639-3BF6-4CB4-BC91-8E0B9C6ABAE5Q33493071-8EE54A65-157E-45A8-8AE3-2781AE9E6D6AQ33529036-FA395CA0-5408-4749-9244-05A8DD5A39BBQ33553810-6C6466EE-A747-44F1-A010-353DBFF632F7Q33706973-2199338C-DF74-4899-82E1-9876B9BA4646Q33759080-50EE21EB-4DB2-4303-BA09-B61A9D1EFB6EQ33954489-092BDAF5-9994-45C2-A41E-54B542155C7BQ34018051-0C0D9C2D-4272-41A7-8B3F-7C5A1DE6A1FAQ34042645-76124D17-6392-4354-8E78-63F70D03B95BQ34119706-AE3D01AF-C9A7-461C-BA80-9CF09AB40243Q34158930-33F491E0-0789-4B5E-B563-A0CD4A047487Q34160138-3F988F84-41BD-46BE-8B7F-B3C33233565FQ34200115-DD50C8A5-6620-4073-BFF1-26DC66417297Q34281340-CFF60FF7-E1E5-45EA-B36B-68376E94FA9DQ34336062-AD39B7F0-4A65-443C-8B26-A0F3F79B7D11Q34343577-6D6AD00A-936E-4E0A-AFB0-32B208C1B6B2Q34414641-62305344-8ECE-4D2B-9AA6-C87FDF1AD3D5Q34483074-FF22BB42-198E-46A8-A2DB-B03814F0563AQ34484412-35461466-52EC-4A4C-987F-12C812015648
P2860
Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation.
@en
Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation.
@nl
type
label
Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation.
@en
Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation.
@nl
prefLabel
Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation.
@en
Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation.
@nl
P2093
P2860
P356
P1433
P1476
Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation
@en
P2093
Alexander Aronshtam
C David Wood
Dwight E Matthews
Gustavo Pedraza-Alva
James L Clements
Mercedes Rincon
Roger J Davis
Tina M Thornton
P2860
P304
P356
10.1126/SCIENCE.1156037
P407
P577
2008-05-01T00:00:00Z